Excaliard Pharmaceuticals, Inc.

The Scottish-born CEO of Pfizer Inc., Ian Read, has revamped the US-based drug maker and turned it into a Wall Street darling over the past five years via a series of moderate-sized acquisitions, spin

Isis Pharmaceuticals founder, CEO and chairman Stanley Crooke knew it would take decades for antisense to prove itself. And while it's taken a few more years than expected for others to acknowledge th

Two pharma-backed venture investment firms put $16 million into a Series A round for a new Southern California dermatology drug company called Thesan Pharmaceuticals, which is run by Gordon Foulkes -

Antisense drug discovery platform operator Ionis Pharmaceuticals Inc. said June 29 that it has entered its second collaboration with Biogen Inc. this year, a deal to develop a therapy for dege